BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33454355)

  • 1. The impact of oral contraceptive use on breast cancer risk: State of the art and future perspectives in the era of 4P medicine.
    Bonfiglio R; Di Pietro ML
    Semin Cancer Biol; 2021 Jul; 72():11-18. PubMed ID: 33454355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and breast cancer risk among younger women.
    Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
    J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 1996 Jun; 347(9017):1713-27. PubMed ID: 8656904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contraception and breast cancer].
    Kottler ML; Gorins A
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):21-6. PubMed ID: 2068480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives in relation to breast cancer.
    Malone KE; Daling JR; Weiss NS
    Epidemiol Rev; 1993; 15(1):80-97. PubMed ID: 8405215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal contraceptive use and breast cancer in Thai women.
    Poosari A; Promthet S; Kamsa-ard S; Suwanrungruang K; Longkul J; Wiangnon S
    J Epidemiol; 2014; 24(3):216-20. PubMed ID: 24614914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
    Contraception; 1996 Sep; 54(3 Suppl):1S-106S. PubMed ID: 8899264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives and risk of breast cancer.
    Paul C; Skegg DC; Spears GF
    Int J Cancer; 1990 Sep; 46(3):366-73. PubMed ID: 2394503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription contraceptives: countering the risks.
    Ruggiero RJ
    Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
    N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and breast cancer.
    Schlesselman JJ
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1379-87. PubMed ID: 2220962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of contraception on gynecologic cancers.
    Herbst AL; Berek JS
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1980-5. PubMed ID: 8512041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal contraception: benefits versus risks.
    Goldzieher JW
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1023-8. PubMed ID: 3674179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.